153 related articles for article (PubMed ID: 12002767)
1. CD19 expression and growth inhibition of tumours in human multiple myeloma.
Ishikawa H; Tsuyama N; Mahmoud MS; Fujii R; Abroun S; Liu S; Li FJ; Kawano MM
Leuk Lymphoma; 2002 Mar; 43(3):613-6. PubMed ID: 12002767
[TBL] [Abstract][Full Text] [Related]
2. Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.
Mahmoud MS; Fujii R; Ishikawa H; Kawano MM
Blood; 1999 Nov; 94(10):3551-8. PubMed ID: 10552966
[TBL] [Abstract][Full Text] [Related]
3. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of Pax-5 gene in human myeloma cells.
Mahmoud MS; Huang N; Nobuyoshi M; Lisukov IA; Tanaka H; Kawano MM
Blood; 1996 May; 87(10):4311-5. PubMed ID: 8639790
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic difference of normal plasma cells from mature myeloma cells.
Harada H; Kawano MM; Huang N; Harada Y; Iwato K; Tanabe O; Tanaka H; Sakai A; Asaoku H; Kuramoto A
Blood; 1993 May; 81(10):2658-63. PubMed ID: 8490175
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
Zheng X; Abroun S; Otsuyama K; Asaoku H; Kawano MM
Haematologica; 2006 Jul; 91(7):920-8. PubMed ID: 16818279
[TBL] [Abstract][Full Text] [Related]
7. The presence of circulating clonal CD19+ cells in multiple myeloma.
Rasmussen T
Leuk Lymphoma; 2001; 42(6):1359-66. PubMed ID: 11911420
[TBL] [Abstract][Full Text] [Related]
8. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
9. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
10. [Identification and targeting of multiple myeloma stem cells].
Hosen N
Nihon Rinsho; 2015 May; 73(5):816-22. PubMed ID: 25985637
[TBL] [Abstract][Full Text] [Related]
11. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of plasma cells.
Rawstron AC
Curr Protoc Cytom; 2006 May; Chapter 6():Unit6.23. PubMed ID: 18770841
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
14. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
16. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Sati HI; Apperley JF; Greaves M; Lawry J; Gooding R; Russell RG; Croucher PI
Br J Haematol; 1998 May; 101(2):287-95. PubMed ID: 9609524
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
[TBL] [Abstract][Full Text] [Related]
19. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
[TBL] [Abstract][Full Text] [Related]
20. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
Otsuyama K; Asaoku H; Kawano MM
Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
